Patents Examined by Daniel Sullivan
  • Patent number: 8883128
    Abstract: The present invention is directed to a cosmetic composition containing: (a) at least one propylphenylsilsesquioxane resin; (b) at least one cosmetically-acceptable aromatic solvent; (c) at least one colorant, and (d) optionally, at least one co-solvent, and wherein the composition is substantially free of volatile solvents. Also disclosed is a method of imparting lasting shine onto lips by contacting the lips with the above described composition.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: November 11, 2014
    Assignee: L'Oréal
    Inventors: Hy Si Bui, Mohamed Kanji
  • Patent number: 8883194
    Abstract: The present invention utilizes a combination of a porous carrier and an adsorbent such as a molecular sieve to make a more effective hemostatic device to treat wounds in mammalian animals. These hemostatic devices contain additives that do not inhibit hemostasis.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: November 11, 2014
    Assignee: Honeywell International, Inc.
    Inventors: Robert L. Bedard, Steven A. Wilcher
  • Patent number: 8877170
    Abstract: The present disclosure relates to implantable medical devices having a non-bioabsorbable substrate and an amphiphilic coating covalently bonded to the substrate for reducing the inflammatory response to the device after implantation.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: November 4, 2014
    Assignee: Sofradim Production
    Inventors: Sebastien Ladet, Philippe Gravagna
  • Patent number: 8877164
    Abstract: Aerosol solution formulation for use in an aerosol inhaler which includes at least one active ingredient selected from 20-ketosteroids and quinolinone derivatives, a propellant containing a hydrofluoroalkane, a cosolvent, and a specific amount of a sequestering agent that stabilizes the formulation. By way of example, the stabilizing agent may be phosphoric acid or sulphuric acid.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: November 4, 2014
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: David Andrew Lewis, Brian John Meakin, Maurizio Delcanale, Fausto Pivetti
  • Patent number: 8865194
    Abstract: Skin-protecting ointment compositions are disclosed that include a greasy material, a safe and minimally absorbed solid, and optionally, a phospholipid composition, and that exhibit reduced greasiness and tackiness relative to an otherwise identical composition lacking the safe and minimally absorbed solid and the optional phospholipid composition. Also disclosed are methods of making such skin-protecting ointment compositions. In one embodiment, the skin-protecting ointment composition comprises a safe and minimally absorbed solid, a lipid thickener, an ointment-like material, a volatile oil, and optionally a phospholipid composition.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: October 21, 2014
    Assignee: Theraplex Company, LLC
    Inventors: Eugene H. Gans, Hans R. Suess
  • Patent number: 8865134
    Abstract: Chewing gum comprising an extract from coffee enriched in at least one ester formed between a trans-cinnamic acid and quinic acid wherein the amount of said at least one ester in the gum is 0.1 to 50 wt %.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: October 21, 2014
    Assignee: Med-Eq AS
    Inventor: Nils Mortensen
  • Patent number: 8859618
    Abstract: This invention is a composition comprising a cyclic siloxane, a silicone occlusive fluid, a silicone occlusive gel, and a silicone resin powder. The composition is useful for wound healing.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: October 14, 2014
    Assignee: Valeant Pharmaceuticals International
    Inventors: Irwin Palefsky, Ni'Kita Wilson
  • Patent number: 8840876
    Abstract: An antimicrobial composition comprising: a complex of an anionic polyester with an antimicrobial cationic surfactant, wherein the anionic polyester has at least one carboxylic group. A medical device having an antimicrobial composition comprising: a complex of an anionic polyester with an antimicrobial cationic surfactant wherein the anionic polyester has at least one carboxylic group.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: September 23, 2014
    Assignee: Ethicon, Inc.
    Inventors: Modesto Eemeta, Robert Di Luccio, Xintian Ming
  • Patent number: 8834906
    Abstract: Disclosed herein are a color capsule composition, which contains a polymer and a plasticizer swelling the polymer so as to allow the capsule particles to easily break and in which the capsule particles have a porous structure that boosts the effects thereof, and a method for preparing the color capsule composition. The preparation method comprises: uniformly mixing a color pigment, a plasticizer and a polymer in a first solvent to produce a first mixture solution; spray-drying the first mixture solution to produce core particles in which the color pigment is covered by the polymer; uniformly mixing the obtained core particles, a functional pigment and a second solvent to produce a second mixture solution; and spray-drying the second mixture solution to produce in which a coating layer of the functional pigment is formed on the outer surface of the polymer.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: September 16, 2014
    Assignee: Biogenics, Inc.
    Inventors: Chul-Hwan Kim, Tae-Sung Ko, Han-Joon Kim, Choa-Jin Kim, Jong-Hyun Choi, Chang-Hun Ji
  • Patent number: 8821437
    Abstract: Biological materials such as vaccines can be stabilized in certain glassy materials soluble in water. It has been proposed to form these glassy materials as a powder suspended in a non-aqueous liquid for injection into a patient. This method is complicated by the need to find suitable compatible liquids and to stop the glassy particles from congregating in liquid. These problems have been obviated by supporting the glassy material on a porous membrane remote from the eluant. When the biological material requires administration, the eluant can be passed across the membrane dissolving the glass and causing the substance to be carried by the liquid into the patient.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: September 2, 2014
    Assignee: NOVA Bio-Pharma Technologies Limited
    Inventors: Samodh de Costa, Bruce Roser, Shevanti Sen
  • Patent number: 8815222
    Abstract: An anhydrous liquid antiperspirant/deodorant composition comprising a carrier comprising a cation and/or zwitterion and a hydrogen bond donor, wherein an amount of carrier is greater than an amount of any other material in the composition, and an antiperspirant active. This represents a new delivery form for antiperspirant actives and/or deodorant actives.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: August 26, 2014
    Assignee: Colgate—Palmolive Company
    Inventors: Long Pan, Donghui Wu, LaTonya Kilpatrick-Liverman, Matthew J. Eibling, Michael Fitzgerald, Iraklis Pappas
  • Patent number: 8808739
    Abstract: The invention relates to a process for the preparation of a pharmaceutical intermediate, comprising the steps of (i) mixing (a-i) sildenafil base, (b-i) wicking agent, (c-i) disintegrant, (d-i) optionally glidant; (ii) compacting the mixture; and (iii) milling the compacted material; and to an intermediate obtainable by that process. In addition, the invention relates to a process for the preparation of an orally dispersible tablet (hereinafter also referred to as an “orodispersible tablet”) comprising the intermediate of the invention, and to orodispersible tablets obtainable by that process.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: August 19, 2014
    Assignee: ratiopharm GmbH
    Inventors: Sven Winter, Max-Werner Scheiwe, Dieter Swatschek
  • Patent number: 8802067
    Abstract: Utilisation of (meth)acrylic comb copolymers with side chains of the hydroxy and alkoxy polyalkylene glycol type in which are present both ethylene oxide and propylene oxide links. These copolymers give a styling effect and an elimination of rinsing. The invention also relates to a cosmetic formulation containing such structures as well as a hair treatment process based on this formulation.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: August 12, 2014
    Assignee: Coatex S.A.S.
    Inventors: Jean-Marc Suau, Olivier Guerret
  • Patent number: 8795692
    Abstract: PEG-free, cold-preparable, prolonged-stability, low-viscosity, fine oil-in-water emulsions, their preparation from preferably clear oil phases or via preferably clear to transparent microemulsion-like concentrates, the corresponding oil phases or microemulsion-like concentrates and the use of the inventive emulsions for producing cosmetic, dermatological, pharmaceutical or industrial formulations, especially for the production of impregnating emulsions for wet wipes or for sprayable care emulsions are provided.
    Type: Grant
    Filed: January 24, 2007
    Date of Patent: August 5, 2014
    Assignee: Evonik Degussa GmbH
    Inventors: Peter Hameyer, Jürgen Meyer, Gabriele Polak
  • Patent number: 8790926
    Abstract: The present disclosure relates to supports and scaffolds for cell and tissue engineering. The supports disclosed herein are composed of a thermally responsive material, containing pillars, that is coated with an acrylic polymer, thereby imparting an amphipathic matrix foundation. When exposed to a change in temperature, the coated support reacts by facilitating or repelling hydromolecular interactions. Further disclosed herein are methods for making hydrogels that can support tissue growth.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: July 29, 2014
    Assignee: Empire Technology Development LLC
    Inventor: Seth Miller
  • Patent number: 8784899
    Abstract: The present invention relates to compositions comprising a vitamin E analog and an arsenic compound for treating hyperproliferative cells disorders such as cancer. The composition of the invention potentiates arsenic toxicity towards cancer cells and can also prevent arsenic-mediated toxicity of non-cancerous cells.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: July 22, 2014
    Assignee: Samuel Waxman Cancer Research Foundation
    Inventors: Wilson H. Miller, Zuanel Diaz Heredia, Hyman M. Schipper, Koren K. Mann
  • Patent number: 8784789
    Abstract: An aqueous liquid preparation containing (+)-(S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid or a pharmacologically acceptable acid addition salt thereof, which is stabilized with a water-soluble metal chloride, is provided.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: July 22, 2014
    Assignee: Senju Pharmaceutical Co., Ltd.
    Inventor: Masayo Higashiyama
  • Patent number: 8778409
    Abstract: A composition, system and method for modifying an olfactory response to an odorant is disclosed. In some embodiments, the composition includes crystalline metal nanoparticles dispersed in an aqueous medium. The composition is applied to olfactory tissues using a suitable applicator or dispenser. The metal nanoparticles are believed to interact with a G-protein coupled to receptor located in the cilia to moderate (enhance or reduce) sensitivity or ability to smell particular odorants. In accordance with an embodiment of the invention, the composition includes one or more odorants.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: July 15, 2014
    Assignee: Auburn University
    Inventors: Vitaly J. Vodyanoy, Lewis G. Scharpf, Alexandre Samoylov, Nilmini Viswaprakash, Ludmila Petrovna Globa, Edward E. Morrison
  • Patent number: 8778320
    Abstract: It is intended to provide a novel deodorant composition which is excellent in the deodorizing effect, is capable of affording a deodorant composition by a convenient method, and shows no decrease in the deodorizing performance even after a long period of time, once the deodorant being prepared. Specifically, there is provided a deodorant composition containing, as the active component, a colored compound obtainable by reacting a polyphenol in a solvent showing alkalinity in the coexistence of an oxygen molecule at a reaction pH value of 6.5 or more. As a substitute for a polyphenol, use can be made of a plant extract containing a polyphenol but containing substantially no amino acid. It is also possible to further employ an amino acid. Furthermore, use can be made of a plant extract and/or a plant body containing a polyphenol and an amino acid.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: July 15, 2014
    Assignee: Takasago International Corporation
    Inventors: Tadahiro Hiramoto, Ryo Takeuchi
  • Patent number: 8778313
    Abstract: Enhanced SPF and/or reduced fluffing fluid compositions for photoprotecting the skin and/or the hair against the damaging effects of ultraviolet radiation, contain: (a) at least one photoprotective system capable of screening out UV radiation; and (b) at least one ester-terminated poly(ester amide) (ETPEA) polymer, formulated into (c) a topically applicable, cosmetically acceptable aqueous support therefor; the subject aqueous compositions are advantageously vaporizable, especially in the form of sprays, confined within a pressurization device.
    Type: Grant
    Filed: January 17, 2007
    Date of Patent: July 15, 2014
    Assignee: L'Oreal
    Inventors: Martin Josso, Cyril Chevalier, Anne-Laure Gaudry